Price to Sales ratio Analysis of Lyra Therapeutics Inc - Deep Dive
Latest FY PS
Period Ending - Dec-23
Very Poor PS
9.47
Period Ending - Dec-22
Very Poor PS
6.00
Growth
57.77 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
4055.42
PS Analysis of Lyra Therapeutics Inc
P/S Ratio of Lyra Therapeutics Inc with value of 4055.42 indicates that stock price is high compared to sales of the company and may be overvalued. |
PS Ratio of LYRA rose handsomely by 57.77 % this year. |
PS Ratio with value of 12.34 was highest in Year Dec-21 in last Five Years. |
PS Ratio with value of 0 was lowest in Year Dec-20 in last Five Years. |
Latest PS Ratio with value of 9.47 is Greater than Average PS of 5.56 in last five years. |
Other PS Related Info of LYRA that may interest you.
Lyra Therapeutics Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
LYRA | 0.2705 | 0.2952 | 8.37 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
Poor Value Stock |
FY - Historical Price to Sales of Lyra Therapeutics Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
---|---|---|---|---|---|---|
PS | 9.47 | 6.00 | 12.34 | 0 | 0 | 1.36 |
Change | 57.77 % | -51.37 % | 0 % |
FY Chart of Price to Sales of Lyra Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)